Filing Flows › Amgen (AMGN) › Net income
Amgen (AMGN) net income by quarter
Amgen's net income was $3.9B in Q3 2026 (third quarter 2026), +63% from Q2 2026. Over the last 7 quarters it ranged from $1.3B (Q4 2025) to $3.9B (Q3 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.9B | +63% | +20% |
| Q2 2026 | $2.4B | +31% | +66% |
| Q1 2026 | $1.8B | +36% | +5% |
| Q4 2025 | $1.3B | -59% | — |
| Q3 2025 | $3.2B | +125% | — |
| Q2 2025 | $1.4B | -17% | — |
| Q1 2025 | $1.7B | — | — |
Q3 2026 at a glance
Amgen, Q3 2026: revenue $10.4B (+8% year over year), operating margin 35.8%, net earnings $3.9B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
Questions
What is Amgen's net income?
Amgen's net income was $3.9B in Q3 2026 (third quarter 2026), +63% from Q2 2026.
How has Amgen's net income changed?
Over the last 7 quarters it ranged from $1.3B (Q4 2025) to $3.9B (Q3 2026).